Non-Hodgkin's Lymphoma (CD20+)
1 clinical trials · Condition
◉ Watch Non-Hodgkin's Lymphoma (CD20+)
| Record | Firm | Date |
|---|---|---|
| Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma (NCT00280878) | Bayside Health | 2006-01-01 |
Track Non-Hodgkin's Lymphoma (CD20+) automatically
Every clearance here is in the API, with alerts when new ones post.